• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立和评估癌症恶病质小鼠模型的方案。

Protocol for establishing and evaluating a cancer cachexia mouse model.

机构信息

Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

出版信息

STAR Protoc. 2024 Sep 20;5(3):103281. doi: 10.1016/j.xpro.2024.103281. Epub 2024 Aug 31.

DOI:10.1016/j.xpro.2024.103281
PMID:39217610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403044/
Abstract

Cancer cachexia mouse models are needed to recapitulate the clinical features of patients with cachexia. Here, we present a protocol for the establishment and evaluation of cancer cachexia mouse models. We delineate the steps in preparing tumor cells for inoculation and surgical procedures. After the establishment of these mouse models, we describe essential techniques to assess cancer cachexia, including grip strength evaluation, tissue collection, and the calculation of cross-sectional areas of muscle tissue. For complete details on the use and execution of this protocol, please refer to Liu et al., Yang et al., Shi et al., and Zhou et al..

摘要

需要建立癌症恶病质小鼠模型来重现恶病质患者的临床特征。在这里,我们提供了一种建立和评估癌症恶病质小鼠模型的方案。我们详细说明了为接种和手术准备肿瘤细胞的步骤。在建立这些小鼠模型后,我们描述了评估癌症恶病质的基本技术,包括握力评估、组织采集和肌肉组织横截面积的计算。如需详细了解本方案的使用和执行,请参考 Liu 等人、Yang 等人、Shi 等人和 Zhou 等人的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/9a2b04855267/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/97c0a35bf29d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/128b1bed17a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/182a90197b0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/9a2b04855267/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/97c0a35bf29d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/128b1bed17a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/182a90197b0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc2/11403044/9a2b04855267/gr3.jpg

相似文献

1
Protocol for establishing and evaluating a cancer cachexia mouse model.建立和评估癌症恶病质小鼠模型的方案。
STAR Protoc. 2024 Sep 20;5(3):103281. doi: 10.1016/j.xpro.2024.103281. Epub 2024 Aug 31.
2
Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.甘氨酸给药可减轻癌症恶病质小鼠模型的骨骼肌消耗。
Clin Nutr. 2014 Jun;33(3):448-58. doi: 10.1016/j.clnu.2013.06.013. Epub 2013 Jun 26.
3
Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.脂联素受体激动剂 AdipoRon 的给药通过减轻荷瘤小鼠的炎症缓解癌性恶病质。
J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):919-933. doi: 10.1002/jcsm.13454. Epub 2024 Apr 4.
4
Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.冬凌草甲素主要通过抑制 STAT3 信号通路改善癌症恶病质相关的肌肉萎缩。
Phytomedicine. 2022 Jan;95:153858. doi: 10.1016/j.phymed.2021.153858. Epub 2021 Nov 15.
5
Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.癌症恶病质的小鼠模型:后肢肌肉质量和诱发力作为读出参数。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2415-2420. doi: 10.1016/j.bbrc.2018.06.170. Epub 2018 Jul 6.
6
Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.在小鼠中对诱导癌症恶病质的 C26 结肠癌细胞的分子、细胞和生理学特征进行分析。
BMC Cancer. 2010 Jul 8;10:363. doi: 10.1186/1471-2407-10-363.
7
Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.胰腺癌所致恶病质的分子与生理学评估
Methods Mol Biol. 2019;1882:321-333. doi: 10.1007/978-1-4939-8879-2_28.
8
Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: lessons from human and animal studies.癌症恶病质相关骨骼肌减少和功能丧失的表型特征:来自人体和动物研究的教训。
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):252-273. doi: 10.1002/jcsm.12678. Epub 2021 Mar 30.
9
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.携带结肠26癌的荷瘤小鼠作为癌症恶病质研究模型。
J Vis Exp. 2016 Nov 30(117):54893. doi: 10.3791/54893.
10
Protocol for establishing spontaneous metastasis in mice using a subcutaneous tumor model.建立小鼠皮下肿瘤模型用于自发转移的实验方案。
STAR Protoc. 2024 Sep 20;5(3):103239. doi: 10.1016/j.xpro.2024.103239. Epub 2024 Aug 2.

引用本文的文献

1
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model.在HT1080肿瘤模型中,塞尔帕替尼可减轻癌症恶病质,且与抗肿瘤活性无关。
Cancer Lett. 2025 Jan 6;611:217444. doi: 10.1016/j.canlet.2025.217444.